Low-dose venlafaxine-associated liver toxicity in chronic hepatitis
Yükleniyor...
Dosyalar
Tarih
2004
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Harvey Whitney Books Co
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Venlafaxine is metabolized in the liver by the isoenzyme CYP2D6. Venlafaxine-associated adverse effects have been reported, such as gastrointestinal and autonomic effects. With the usage of
high dosages of venlafaxine,1 adverse effects such as toxic hepatitis have
been reported,2,3 but toxic hepatitis has not been reported at low doses of
venlafaxine such as 37.5 mg/day. We report a case of probable toxic hepatitis associated with a low dose of venlafaxine in a patient with a history
of chronic hepatitis.
Açıklama
Anahtar Kelimeler
Chronic Hepatitis, Liver Toxicity, Venlafaxine
Kaynak
Annals Of Pharmacotherapy
WoS Q Değeri
Q3
Scopus Q Değeri
Q1
Cilt
38
Sayı
2
